Medical Conditions - Urothelial Carcinoma

The combination of Nivolumab with Cisplatin and Gemcitabine is one of the advances, demonstrating better survival in patients with urothelial carcinoma.

Have you heard of a treatment that trains the immune system to fight cancer effectively? That is immunotherapy, an approach for treating urothelial cancer.

It is possible to reduce the risk of developing urothelial carcinoma. Habits such as a balanced diet and not smoking are some of the factors that can be controlled.

Managing urothelial cancer post-treatment requires consuming plenty of fruits and whole grains as part of a healthy diet.

The current landscape of treatment for metastatic urothelial carcinoma can change based on the patient's age and medical history. Let’s explore below.

Advanced urothelial carcinoma is a type of cancer that affects the cells that line the bladder and the urinary tract. Check out the article below.

Let’s learn about urothelial carcinoma in situ, its symptoms, treatment options, and how to manage it and prevent it from returning.

Urothelial cancer often precipitates symptoms like incontinence or painful urination, and sometimes frequent urine discharge occurs subsequently.

Did you know some bladder cancers stay on the surface without deep invasion? That’s noninvasive papillary carcinoma, with a good prognosis if caught early.

Did you know that invasive urothelial carcinoma can spread beyond the bladder lining, affecting deeper tissues and even nearby organs? Read below.